Background The authenticity of various prototype human placental extracts with biological activity, such as that inducing vitiligo repigmentation, is under serious criticism, mainly due to a lack of demonstration at the cellular level. Considering the present worldwide scenario with regard to the occurrence and treatment of vitiligo, a thorough scientific exploration of such extracts should be undertaken.
Introduction
Human placenta is an extremely rich reservoir of bioactive molecules. Some typical human placental extracts contain keratinocyte growth factor 1, 2 or stimulators of endothelial cell growth. 3 In the human placenta, the occurrence of bioactive peptides, such as endothelin-1 (ET-1), 4 ,5 adrenocorticotropic hormone (ACTH), 6, 7 and sphingolipids, 8, 9 well-known modulators of different cellular responses, has already been documented. ET-1 is a versatile peptide, originally identified as a vasoactive component, demonstrating significant mitogenic, 10 dendricity-inducing, 11, 12 and melanogenic 13 activities on melanocytes. Moreover, ACTH has been reported to play an important role in melanogenesis. 14 Sphingolipids and their metabolites act as crucial second messenger molecules controlling a delicate rheostatic switch to balance cell growth promotion and inhibition signals.
More interestingly, the physiologic growth and pigmentation of melanocytes show an inverse relationship; therefore, the switching actions of sphingolipid metabolites are of paramount importance in melanogenic induction. An alcoholic human placental extract ("Melagenina") has been claimed to be useful for pigment recovery in vitiligo, but did not stand up to this claim due to a lack of adequate scientific evidence. Thus, there was a need to provide authentic data with regard to its composition and the bioactive molecule(s) responsible for its therapeutic action. Extensive propositions were made for biological studies of the material at the cellular level using single cell cultures of melanocytes. 18 There are constant and serious demands, however, to have an extract of term human placenta containing important biomolecules, which would demonstrate the modulation of melanocyte activity, explicitly its proliferation, migration, and melanization. In vitiligo, melanocyte destruction at the sites of the lesions is immediately obvious; only the cells residing mainly at the outer root sheath of the hair follicles (in the vitiliginous areas) survive in the inactive (dopa-negative) form, together with a few live melanocytes in the epidermal regions and at the edge of vitiligo lesions. For the recovery of skin color, modulations of these cells in terms of their growth, migration, and melanogenesis are essential prerequisites.
In view of this, a prototype alcoholic placental extract was prepared 19 using human immunodeficiency virus (HIV)-and hepatitis B antigen-negative term human placenta, which was found to harbor a large number of biomolecules, including sphingolipids and small peptides. 20 During an early experiment with a young guinea pig, used as a preliminary animal model, the extract resulted in the darkening of the areola region around the nipples. 20 Two important bioactive peptides, ET-1 and ACTH, known to have a significant modulatory role on melanocyte activity, have already been identified in this extract. 21 In this report, we demonstrate the effectiveness of the extract in an in vivo experiment studying melanization and hair growth in C57BL /6J mice. Moreover, the (alcohol-free) extract constituents stimulated the growth and melanogenesis of melanocyte/melanoma cells, together with morphologic alterations, under in vitro culture conditions. Although the study itself is preclinical, it should be judged by its clinical insinuation. It is at the threshold of the clinical segment of the schedule, and has some clinical back-up in the form of a short-term randomized clinical trial.
Materials and methods

Preparation of the human term placental alcoholic extract and estimation of relevant biopeptides
We prepared an alcoholic extract of fresh, term, HIV-and hepatitis B-negative (both from mothers' venous and babies cord blood samples) human placenta, as mentioned previously. 19, 20 HIV and hepatitis B were screened by enzyme-linked immunoabsorbent assay (ELISA) techniques using kits from Biochem
Immunosystem, Canada, and Abott Diagnostics, USA, respectively. The tissue material was first washed, followed by trituration and temperature-controlled alcohol extraction.
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Quantification of the extracted amounts of some specific lipidassociated and melanocyte response-modifying bioactive peptides was used to monitor the extraction parameters.
Subsequently, both qualitative and quantitative assays of ET-1 and ACTH were carried out as described previously 21 in the extract or fractions thereof following standard ELISA (ELISA assay kit, Amersham Inc., USA) and radioimmunoassay (RIA) 22 (RIA assay kit, Immunotech, France) techniques (Table 1) .
Application of the extract on telogenic C57BL/6J mouse skin C57BL /6J black mice with age-induced early gray body coat hair, pinkish skin, and histologic "melanocyte disappearance," 23, 24 indicating the initiation of a prolonged telogenic phase of hair growth, were used as in vivo animal models to assess the pigment-inducing activity of the placental extract. In this condition, pigment recovery in the skin, together with fresh hair growth, could be considered synonymous with the induced growth and melanogenesis of melanocytes, concurring with repigmentation in The selected portion of C57BL /6J mouse skin was first clipped to remove early gray body coat hair and, on the telogenic pinkish skin, alcoholic extract was applied dropwise (0.2 mL /cm (100 U/mL and 100 µ g/mL, respectively) and used throughout the studies.
H-Thymidine incorporation
For mitogenesis studies on B16F10 mouse melanomas, cells were grown in medium supplemented with 2% fetal calf serum (FCS) in a humidified atmosphere of 5% CO 2 in an incubator at 37 ° C. Cell proliferation assay was performed as reported previously. 27, 28 Briefly, 3 × 10 4 cells/cm 2 were seeded in 96-well plates. After cell adherence by overnight incubation, the stimulants in the form of extract constituents in alcohol-free phosphate-buffered saline (PBS) emulsion were added in triplicate for each dose.
Subsequently, the culture was incubated for 24 h and harvested thereafter. 
Melanin assay
Melanin assay was performed according to the procedure of Naeyaert et al . 29 In short, 4 × 10 5 cells/cm 2 were seeded in six-well plates and incubated overnight for attachment, followed by the addition of the stimulants in duplicate and subsequent incubation for 48 h. The cells were then sequentially washed with PBS, trypsinized, harvested, pelleted, and dissolved in 1 mL of 1 N NaOH to measure the absorbance at 475 nm ( λ max = 475 nm).
Commercially available synthetic melanin (Sigma) was used as standard.
Results
Application of the extract on C57BL/6J mice
On completion of the extract application course of 4 weeks, the skin color of the telogenic pinkish skin of aged C57BL /6J mice reverted to its anagen-like condition only at the placental extract-treated site and not at the vehicle-treated site (Fig. 1) . The skin color changed to light bluish at first with further progressive darkening. Simultaneously, shiny black hair appeared in the extract-treated region with an appearance similar to that found in young animals. This growth was steadily maintained throughout the whole application period. Figures 2a and 2b show the results of application of the 60% alcohol vehicle and the extract, respectively, on separate sets of mice in a parallel experiment The results were in agreement with those shown in Fig. 1 . 
Histologic examination
Skin specimens from both the extract-and vehicle-treated sites were examined histologically on both cross-sectional and longitudinal views. The alterations in skin organization, melanization, and hair follicle formation were remarkable at the extract-treated site only. Figure 3a and 3b show the cross-sectional views of the vehicle-and extract-treated skin specimens, respectively, whereas Fig. 4a and 4b show the corresponding longitudinal views. Both control slides (Figs 3a and 4a) are mostly hypotrophic. In the cross-sectional view of the experimental specimen, a significant enhancement in the number of melanizing centers, together with invagination at the top of the upper epidermis resembling the initiation of hair follicle growth, was observed in agreement with earlier reports 30, 31 (Fig. 3b) . In the longitudinal view, new hair follicle development was vividly distinct (Fig. 4b) . Along the wall of the new hair follicle well, cells similar in appearance to migratory melanocytes were observed (identified by MasonFontana staining for melanin), with fairly large hair bulbs at the root (the size of the adipocyte layers, photographed under the same magnification, can be compared between the control and experimental sets). In the extract-treated skin section, the increase in the number of hair follicles was reflected by an enhancement in the number of melanizing centers. The roots of the newly developed hair bulbs passed beyond the dermis and embedded into the adipocyte layer (Fig. 4b, marked as  arrow) .
In vitro effect of extract on B16F10 mouse melanoma cells
The mitogenic and melanogenic effects of the placental extract constituents (in the alcohol-free condition) were assessed on the fast growing mouse melanoma cells, B16F10. Figure 5 demonstrates the mitogenic effect of the alcohol-free extract constituents, as measured by 3 H-thymidine incorporation. It is clear that the promotion of cell growth can be attributed to the low concentration of extract constituents (maximum at a dose of 50 µ g /mL), whereas a high concentration induces growth inhibition. The effect was so prominent that, at a dose of 1000 µ g /mL, 3 H-thymidine incorporation was less than half of that found for the control. More significantly, Fig. 6 illustrates that the growth inhibitory concentrations of the extract constituents promote melanization, with an optimum at a dose of 500 µ g /mL. Thus, the extract is enriched with biomolecules capable of modulating both mitogenesis and melanogenesis of melanoma cells (B16F10) in a concentration-dependent manner.
Determinations of ET-1 and ACTH in the extract
The two significant melanocyte response-modifying bioactive peptides, ET-1 and ACTH, were assayed 21 in the extract concerned ( Table 1 ). The quantities found were, on average, 112.0 pg /mL and 4.0 pg /mL, respectively. Interestingly, the majority of the two peptides were found in the lipid fractions, thus indicating a plausible lipid-peptide association with wide significance. 
Discussion
In this study, we have demonstrated that an alcoholic human placental extract induces melanogenesis in both an in vivo mouse model and an in vitro cell culture system. Age-induced prolonged telogenic phase of hair growth with the histologic disappearance of melanocytes in C57BL/6J mice 24 is a condition comparable to the disappearance of melanocytes in vitiligo depigmentation. The appearance of fresh black hair demonstrates the reversal of the telogenic phase to the anagenic phase of the hair growth cycle, thus illustrating the melanogenic action of the extract. In the surrounding ventral region of the extract-treated zone, graying of the hair continued, resembling the vehicle-treated area. Previously, it has been reported that an extract composed of peptides, amino acids, and different classes of lipid, including sphingolipids, causes skin darkening in a guinea pig model. 20 Histologic examination explicitly illustrated an enhancement in the number of melanin-forming centers and the development of new hair follicles, together with invagination at the top of the epidermis. This is conspicuously similar to the proposed model for the development of new hair follicles. 32 The new follicles were not only larger in size, but also passed into the adipocyte layer; therefore, they were distinct and proved to be the product of the action of placental extract constituents. The dermis region was hypertrophic compared to that of the control or vehicle-treated skin, which was hypotrophic. Hence, the structural organization of the skin undergoes some remarkable changes. Along the wall of the hair follicle well, upward migratory cells, resembling migratory melanocytes (identified by Mason-Fontana staining for melanin), appeared and were found to be distributed in the upper epidermis (Fig. 4b) . The results in this study are similar to those found by Cui et al ., 33 and are significant in that this phenomenon of differentiation of the hair follicle premelanocytes into active forms and their subsequent migration to the epidermis are the key events for repigmentation in vitiligo lesions.
The use of IR light during in vivo topical application is beneficial and supportive in two ways. First, it effectively induces vasodilation, causing a significant increase in blood flow. 34 This enhanced blood flow distributes the active constituent(s) more effectively, thus facilitating its action. The interaction of IR light with the vehicle of the extract, alcohol, has some additional importance. Solvents such as alcohol can successfully induce transitory barrier perturbation, 35 facilitating the permeation of active lipid component(s). Penetration and vasodilation in combination efficiently boost the overall action of the extract. 34 IR irradiation is equivalent to heat treatment and can promote the dopa-oxidase activity of melanocytes, together with an enhancement in the number of dopa-positive and tyrosinase-related protein-1-positive melanocytes, in the in vitro condition. 36 In this study, we exposed the experimental animals to irradiation from a distance of 45 cm for a duration of only 5 min at a time, when the temperature did not in any circumstances exceed 38 ° C. Moreover, the time interval between two successive irradiations was a minimum of 5 min and, by this time, the temperature had decreased and was expected to be lower than 38 ° C. Hence, our experimental conditions were substantially less favorable than those reported previously 36 for the promotion of melanocytic activity. Therefore, we can conclude that the IR exposure in this study produced no side-effects equivalent to those of UVB or heat (42 ° C), 36 such as sunburn, tanning, hyperplasia, immunologic changes, photoaging, and even photocarcinogenesis. 37 Lastly, IR use is more cost-effective from the patients' viewpoint.
The effect of the placental extract was also examined in in vitro culture conditions with B16F10 mouse melanoma cells. The results found were quite encouraging from the viewpoint of repigmentation in vitiligo. 38, 39 Low concentrations of the extract constituents promoted a concentration-dependent mitogenesis, which attained a maximum value; with a further increase in concentration, inhibition of growth was induced, and melanogenesis was observed. Moreover, with a further Figure 6 Effect of alcohol-free placental extract constituents on B16F10 mouse melanoma melanogenesis (measured in terms of spectrophotometric absorbance at λ max = 475 nm) increase in concentration, melanogenesis reached an optimum when radioactive incorporation (i.e. mitogenesis) was almost comparable with the control value. This type of rheostatic duality in mitogenic action may be due to the sphingolipid component(s) of the extract. 16, 20 This viewpoint is further supported by an ongoing experiment, in which we have been able to purify a sphingolipid component in a single spot by high-performance thin layer chromatography (HPTLC) from the extract preparation, and observed analogous results (Pal et al ., in preparation) . Possibly, some sort of stress is generated at high concentrations of the extract constituents, where cell growth is inhibited, and this stress condition may, in turn, lead to the induction of melanogenesis, which is a stressinduced phenomenon. 40 Moreover, the extract constituents induce growth suppression only; the cells remain fully viable and growth is resumed as normal after the addition of fresh growth medium (data not shown) devoid of any experimental growth modulator. The growth and melanogenic effects of the extract constituents on B16F10 mouse melanoma cells are confirmed by similar findings with normal human melanocytes (Pal et al ., in preparation) .
The presence of ET-1 and ACTH in the extract 21 is of crucial importance considering their significance in promoting melanocyte activity, such as mitogenesis, migration, and melanogenesis. Moreover, they remain in a highly lipidassociated form: more than 80% of the total in the lipidcontaining organic phase and the remainder in the aqueous fraction (Table 1) . For topical application, the therapeutic peptides do not penetrate the skin effectively, but their penetration can be enhanced by solubilization in alcohol, 41 and /or when they are strongly lipid associated. 35, 42 Thus, the extract, which contains the peptides (together with certain lipid constituent(s)) in their lipid-associated form, is vital in promoting cellular growth and melanization, thereby producing repigmentation.
Therefore, the findings of both in vivo (C57BL /6J mice) and in vitro (B16F10 mouse melanoma cells) studies indicate the presence of activity modulators of melanocyte cells in the extract. Toxicity-related experiments with the extract preparation showed it to be nonmutagenic, noncytotoxic, and totally safe and skin-friendly in nature (Pal et al., in preparation) . Hence, the inherent potency of the alcoholic human placental extract for repigmentation in vitiligo cases should be asserted. This assertion may gain further momentum when the results of a short-term randomized clinical trial on a small number of voluntary vitiligo vulgaris patients, 20, 43 in which highly or moderately satisfactory pigment recovery was documented in more than 50% of cases, are considered. The proposed active components, i.e. bioactive peptides and some lipids, are highly physiologically compatible, so to bear therapeutic integrity. Further characterization of these active components is essential and is part of our future schedule.
